Global Point of Care
Antimicrobial resistance (AMR) is one of the greatest threats to global health, yet it is accelerated mainly by the misuse and unnecessary prescription of antibiotics.1,2 Most antibiotics are prescribed for respiratory tract infections (RTIs) in the primary care setting.3 Implementing C-reactive protein (CRP) point-of-care testing (POCT) has been shown to safely reduce antibiotic prescribing in RTIs4-8 without impacting clinical measures such as rate of recovery or mortality.5-7
Adopting diagnostic systems that markedly reduce antibiotic consumption has been described as a “no-brainer” for governments that are struggling to address the rise in AMR.8
Dr. Margaret Chan, Director General of the World Health Organization (WHO) further emphasizes the importance of incorporating diagnostics into strategies for slowing the spread of AMR.
“Today, antibiotics are rarely prescribed based on a definitive diagnosis. Having rapid, low-cost, and readily available diagnostics is an essential part of the solution to this urgent problem.”
Dr. Margaret Chan, Director General of the World Health Organization9
CRP testing has been shown to achieve a reduction in antibiotic prescribing, especially in subgroups with acutely exacerbated COPD10-12 and in the elderly, with lower RTIs in nursing homes.7 Dr. Carl Llor, PhD, MD (Via Roma Health Centre, Barcelona, and the University of Odense, Denmark) highlights that CRP POCT could also have slowed the spread of AMR during the COVID-19 pandemic.13
A recent educational webcast on myPOCacademy.com looked at how the consumption of antibiotics can be reduced in the primary care setting, and the advantages of adopting CRP POCT to assist in this goal.
The webcast includes presentations from an international expert faculty, plus a patient advocate, Vanessa, who speaks about her personal experiences in dealing with AMR. It also features country-specific perspectives and clinical case studies from across multiple disease areas.
The educational platform myPOCacademy is an expert resource for healthcare professionals, providing a range of professionally accredited learning on POCT. Working with an expert faculty, content covers multiple clinical disciplines, including respiratory health, cardiovascular disease and diabetes. You can hear more about the platform by watching the short introductory video at www.myPOCacademy.com and you can access all the content by registering (for free).
© 2022 Abbott. All rights reserved. All trademarks referenced are trademarks of either the Abbott group of companies or their respective owners. Any photos displayed are for illustrative purposes only.
A Leader in Rapid Point-of-Care Diagnostics.
©2023 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
Abbott - A Leader in Rapid Point-of-Care Diagnostics.